Veeva Vault CDMS delivers on the industry’s urgent need
for
complete and concurrent clinical data for faster insights and execution
PHILADELPHIA--(BUSINESS WIRE)--
2018 Veeva R&D Summit -- Veeva
Systems (NYSE:VEEV) today announced a next-generation cloud
application to streamline clinical data management and accelerate study
execution. Veeva
Vault CDMS eliminates the need for multiple tools with a single
clinical data management application that combines coding, EDC, data
cleaning, and reporting. Companies can now have one application that
allows them to manage study build through execution and gain a complete
and concurrent view of all clinical data within a trial.
“The industry can finally move away from the complex patchwork of
systems and integrations that limit the ability to leverage the range of
clinical data available throughout the course of a trial,” said Henry
Levy, general manager of Veeva Vault CDMS. “Veeva Vault CDMS will
provide the key capabilities companies need to bring together all their
clinical data so research teams can make faster, more informed
decisions.”
Life sciences companies want to use a greater range of data in trials,
but today’s EDC systems only manage a limited volume and diversity of
clinical data.1 This forces organizations to collect, clean,
and analyze data across multiple systems and repositories, restricting
visibility and slowing trial execution.
Veeva Vault CDMS delivers on the need for a complete and concurrent view
of data throughout the trial with one application for data capture,
coding, cleaning, reporting, and management. Companies can now
seamlessly bring data together and have daily access to all their
clinical data during a trial, instead of waiting weeks or months.
Vault CDMS combines the following capabilities into a single, modern
cloud solution:
-
Vault
Coder, available today, codes medical information with speed and
accuracy in Vault CDMS. Streamline medical coding to ensure clinical
teams and CROs are using up-to-date, consistent medical terms across
all their studies.
-
Vault
EDC, also available now, maintains and manages all clinical data,
including non-CRF data, in one central location. Build, manage, and
run studies faster with a modern EDC and significantly improve trial
execution.
-
Vault Data Workbench, planned for availability in late 2019, will
seamlessly bring together all trial data into a consistently formatted
data lake for integrated cleaning, reporting, and export. Synchronize
data automatically from Vault EDC and Vault Coder. Open APIs are
available for a variety of other data sources such as ePRO, medical
imaging, labs, and randomization.
Vault CDMS is part of Veeva
Vault Clinical Suite, which also includes Vault
CTMS, Vault
eTMF, and Vault
Study Startup, to unify clinical
data management and clinical
operations on a single cloud platform. Veeva’s suite of unified
applications provides global visibility of trial processes and data for
organizations to easily manage their entire trial portfolio and
streamline end-to-end clinical processes.
Vault CDMS is now available with Vault EDC and Vault Coder. Expanded
capability with Vault Data Workbench is planned for availability in late
2019. Learn more at veeva.com/VaultCDMS.
Additional Information
For more on Veeva Vault CDMS, visit: veeva.com/VaultCDMS
Connect
with Veeva on LinkedIn: linkedin.com/company/veeva-systems
Follow
@veevasystems on Twitter: twitter.com/veevasystems
Like
Veeva on Facebook: facebook.com/veevasystems
About Veeva Development Cloud
Veeva
Development Cloud is a unified suite of applications for clinical,
regulatory, and quality to help organizations streamline end-to-end
product development processes. Veeva has more than 220 clinical
customers, 140 regulatory customers, and 180 quality customers using
applications to drive greater efficiency and maintain compliance
throughout the product lifecycle.2 Learn more at veeva.com/DevelopmentCloud.
About Veeva Systems
Veeva Systems Inc. is a leader in cloud-based software for the global
life sciences industry and other regulated manufacturers. Committed to
innovation, product excellence, and customer success, Veeva has more
than 650 customers, ranging from the world's largest pharmaceutical
companies to emerging biotechs. Veeva is headquartered in the San
Francisco Bay Area, with offices throughout North America, Europe, Asia,
and Latin America. For more information, visit veeva.com.
Forward-looking Statements
This release contains forward-looking statements, including the market
demand for and acceptance of Veeva’s products and services, the results
from use of Veeva’s products and services, and general business
conditions, particularly in the life sciences industry. Any
forward-looking statements contained in this press release are based
upon Veeva’s historical performance and its current plans, estimates,
and expectations, and are not a representation that such plans,
estimates, or expectations will be achieved. These forward-looking
statements represent Veeva’s expectations as of the date of this press
announcement. Subsequent events may cause these expectations to change,
and Veeva disclaims any obligation to update the forward-looking
statements in the future. These forward-looking statements are subject
to known and unknown risks and uncertainties that may cause actual
results to differ materially. Additional risks and uncertainties that
could affect Veeva’s financial results are included under the captions,
“Risk Factors” and “Management’s Discussion and Analysis of Financial
Condition and Results of Operations,” in the company’s filing on Form
10-Q for the period ended July 31, 2018. This is available on the
company’s website at veeva.com
under the Investors section and on the SEC’s website at sec.gov.
Further information on potential risks that could affect actual results
will be included in other filings Veeva makes with the SEC from time to
time.
1
Tufts Center for the Study of Drug Development,
2017
eClinical Landscape Study
2
As of fiscal
second quarter ended July 31, 2018
View source version on businesswire.com:
https://www.businesswire.com/news/home/20180917005314/en/
Veeva Systems
Roger Villareal, 925-264-8885
roger.villareal@veeva.com
or
Lisa
Barbadora, 610-420-3413
pr@veeva.com
Source: Veeva Systems Inc.